PPIG and metabolic syndrome: The observed lack of CYP interaction up to a compound concentration of 10 μM is a crucial aspect in averting drug-drug interactions, which is of particular relevance for the treatment of metabolic syndrome, where patients frequently require concurrent administration of multiple drugs71.